112 related articles for article (PubMed ID: 33647389)
1. Response to: "Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain? The tip of an iceberg!".
Weng C; Liu Z
Osteoarthritis Cartilage; 2021 May; 29(5):783-784. PubMed ID: 33647389
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain? The tip of an iceberg!
Braillon A
Osteoarthritis Cartilage; 2020 Sep; 28(9):1298-1299. PubMed ID: 32446939
[No Abstract] [Full Text] [Related]
3. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
Williamson OD; Schroer M; Ruff DD; Ahl J; Margherita A; Sagman D; Wohlreich MM
Clin Ther; 2014 Apr; 36(4):544-51. PubMed ID: 24650448
[TBL] [Abstract][Full Text] [Related]
4. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Konno SI; Alev L; Oda N; Ochiai T; Enomoto H
Pain Med; 2019 Aug; 20(8):1479-1488. PubMed ID: 30856270
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials.
Wang ZY; Shi SY; Li SJ; Chen F; Chen H; Lin HZ; Lin JM
Pain Med; 2015 Jul; 16(7):1373-85. PubMed ID: 26176791
[TBL] [Abstract][Full Text] [Related]
6. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
Cutler N
Prim Care Companion CNS Disord; 2017 Feb; 19(1):. PubMed ID: 28196312
[No Abstract] [Full Text] [Related]
7. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
Enomoto H; Fujikoshi S; Tsuji T; Sasaki N; Tokuoka H; Uchio Y
J Orthop Sci; 2018 Nov; 23(6):1019-1026. PubMed ID: 30126675
[TBL] [Abstract][Full Text] [Related]
8. Questions Regarding "Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component".
Bhatia A
Anesthesiology; 2016 Jul; 125(1):255-6. PubMed ID: 27326500
[No Abstract] [Full Text] [Related]
9. Is duloxetine an alternative in the treatment of osteoarthritis?
Ananías J; Irarrázaval S
Medwave; 2017 Oct; 17(8):e7063. PubMed ID: 29053665
[TBL] [Abstract][Full Text] [Related]
10. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta-analysis of randomised controlled trials.
Chen L; Gong M; Liu G; Xing F; Liu J; Xiang Z
Intern Med J; 2019 Dec; 49(12):1514-1523. PubMed ID: 30993832
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain.
Friedmann N; Klutzaritz V; Webster L
Pain Med; 2011 May; 12(5):755-60. PubMed ID: 21481168
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component: A Randomized, Double-blind, Placebo-controlled Crossover Trial.
Schukro RP; Oehmke MJ; Geroldinger A; Heinze G; Kress HG; Pramhas S
Anesthesiology; 2016 Jan; 124(1):150-8. PubMed ID: 26517858
[TBL] [Abstract][Full Text] [Related]
14. Physical Dependence in Patient With Chronic Low Back Pain Treated With Topiramate: A Case Report.
Bratton RH; Ward SA
A A Pract; 2019 Nov; 13(10):376-378. PubMed ID: 31449076
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis.
Osani MC; Bannuru RR
Korean J Intern Med; 2019 Sep; 34(5):966-973. PubMed ID: 30871298
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine Reduces Pain and Improves Quality of Recovery Following Total Knee Arthroplasty in Centrally Sensitized Patients: A Prospective, Randomized Controlled Study.
Koh IJ; Kim MS; Sohn S; Song KY; Choi NY; In Y
J Bone Joint Surg Am; 2019 Jan; 101(1):64-73. PubMed ID: 30601417
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain.
Wild JE; Grond S; Kuperwasser B; Gilbert J; McCann B; Lange B; Steup A; Häufel T; Etropolski MS; Rauschkolb C; Lange R
Pain Pract; 2010; 10(5):416-27. PubMed ID: 20602712
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Wielage R; Bansal M; Wilson K; Klein R; Happich M
Spine (Phila Pa 1976); 2013 May; 38(11):936-46. PubMed ID: 23250234
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
Skljarevski V; Zhang S; Chappell AS; Walker DJ; Murray I; Backonja M
Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants in the treatment for chronic low back pain: questioning the validity of meta-analyses.
Williamson OD; Sagman D; Bruins RH; Boulay LJ; Schacht A
Pain Pract; 2014 Feb; 14(2):E33-41. PubMed ID: 24460577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
